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Guideline	References	and	Academic	Citations	as	Evidence	of	
the	Clinical	Value	of	Health	Research1	
Mike Thelwall, Nabeil Maflahi 
This article introduces a new source of evidence of the value of medical-related research: 
citations from clinical guidelines. These give evidence that research findings have been 
used to inform the day-to-day practice of medical staff. In order to identify whether 
citations from guidelines can give different information from that of traditional citation 
counts, this article assesses the extent to which references in clinical guidelines tend to be 
highly cited in the academic literature and highly read in Mendeley. Using evidence from 
the UK, references associated with the UK’s National Institute of Health and Clinical 
Excellence (NICE) guidelines tended to be substantially more cited than comparable 
articles, unless they had been published in the most recent three years. Citation counts 
also seemed to be stronger indicators than Mendeley readership altmetrics. Hence, whilst 
presence in guidelines may be particularly useful to highlight the contributions of 
recently-published articles, for older articles, citation counts may already be enough to 
recognise their contributions to health in society.  
Introduction	
In order to identify and disseminate best practice for treating patients, many governments 
periodically pool together medical experts to review existing evidence and then formulate 
official guidelines for diagnosis and treatment (Shekelle, Woolf, Eccles, & Grimshaw, 1999; 
Woolf, Grol, Hutchinson, Eccles, & Grimshaw, 1999). In turn, physicians, surgeons, nurses 
and other medical practitioners are then expected to keep up-to-date with relevant 
guidelines but to use their professional judgement when applying them, improving patient 
outcomes (Grimshaw & Russell, 1993). Being cited in a clinical guideline is direct evidence 
that a study has had a societal impact by guiding medical practice. Although guidelines are 
not universally followed  (Fleming, Mackley, Camacho, et al., 2014; Haymart, 2010), they can 
be an authoritative source of information in their own right (Clark, 2011) and may also 
directly influence working protocols for health professionals in particular contexts (Yue, 
Tabloski, Dowal, Puelle, Nandan, & Inouye, 2014). Guidelines also have the advantage that 
they are public documents that can be evaluated post hoc by researchers seeking to identify 
areas for improvement (Deader, Tiboni, Malone, & Fairhurst, 2012; Tabassum & Batty, 
2013). Given the importance of guidelines, when evaluating medical researchers it would be 
appropriate to include information about the guidelines that they have been cited in (e.g., 
Ovseiko, Oancea, & Buchan, 2012). Whilst an individual researcher could add information 
about citations from guidelines to their CV, when evaluating departments or other large 
groups it would be more appropriate to use some form of guideline citation count. 
Guidelines have already started to attract attention from medical research funders 
as potential indicators of societal impact (Kryl, Allen, Dolby, Sherbon, & Viney, 2012). In 
theory, presence in guideline reference lists could serve as evidence that a research funder’s 
money has been useful in ways other than scientific knowledge building. Assessing the value 
of medical funding is of continuing importance (e.g., Glover, Buxton, Guthrie, Hanney, Pollitt 
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& Grant, 2014). Unfortunately, however, guidelines do not always contain references, and, 
when present, these references do not explicitly indicate their value to the guideline (Kryl, 
Allen, Dolby, Sherbon, & Viney, 2012). Nevertheless, if research funders push for references 
to be systematically added to, and labelled in, clinical guidelines then they will form a rich 
and systematic source of impact evidence (Kryl, Allen, Dolby, Sherbon, & Viney, 2012). Of 
course there are likely to be limitations, such as citations of review articles rather than the 
original studies, biases in the guidelines selection committees (e.g., towards their own 
research), and citing follow up studies rather than the original ground breaking research. A 
further problem is that procedures for updating guidelines may not be standardised, even 
within an organisation such as NICE (McFarlane, Barnes, Sanabria, Alonso-Coello, & 
Alderson, 2013). 
Since clinical guidelines have not previously been used for systematic assessments of 
groups of researchers, this article assesses their potential for this, and reports a proof-of-
concept study with the UK’s NICE guidelines (www.nice.org.uk). These are a systematic 
collection prepared by groups of experts brought together by NICE (e.g., Mayberry, Lobo, 
Ford, & Thomas, 2013) and, whilst they do not incorporate references, they are associated 
with Clinical Knowledge Summaries (CKSs), which do. Although these documents form a 
small collection in comparison to the National Guideline Clearinghouse 
(www.guideline.gov), the latter is not a single coherent collection and hence would give less 
clear results. 
Background	
A brief review of patent citation analysis can give insights into guideline citation analysis 
since both genres reflect transitions from theory to practice. A citation to an academic 
article from a patent may reflect the use of academic knowledge in an invention that is 
judged by the assignee to be of potential value, although citations added by examiners do 
not necessarily point to knowledge of the patent inventor (Alcacer & Gittelman, 2006). 
Patent citations are not a universal source of evidence, however, because patents are 
common in some areas, such as pharmaceuticals, but are rare in others, such as psychology 
(Coupe, 2003). Moreover, most patents do not represent commercialisation of research in 
the sense that patenting and technology transfer in general seem to fail most of the time 
(Valdivia, 2013) and because of this, citations to patents have been proposed as indicators 
of the value of the patents (Hall, Jaffe, & Trajtenberg, 2005; Trajtenberg, 1990). Even within 
a field, patent citations offer only a partial picture of technology transfer, with other types 
being hidden, and traditional citations may better reflect the value of academic research 
(Roach & Cohen, 2013). In addition, universities have in the past promoted patenting 
through technology transfer offices, science parks and other methods (Minguillo & Thelwall, 
2012), which seems to have increased the number of patents that do not reflect genuine 
commercial products (Henderson, Jaffe, & Trajtenberg, 1998). In summary, whilst patent 
citations may seem to be useful evidence of commercial value, in practice they are probably 
not, except perhaps in certain narrow contexts. 
One study has analysed citations to the references in clinical guidelines, finding that 
more highly cited references associated with higher quality guidelines (Andersen, 2013) but 
it did not assess whether references in guidelines could be a source of impact evidence for 
the scholars that published the articles. Another study showed that the references in UK 
cancer guidelines had a bias towards UK-based sources of evidence, tended to draw 
disproportionately on funded research, and revealed the geographic origins of the research 
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informing the guidelines (Lewison, 2007; Lewison, & Sullivan, 2008). Finally, clinical 
guidelines can themselves be discussed and cited in an attempt to publicise their 
recommendations to practitioners (Stenke & Hussey, 2014). 
Research	questions	
It is not possible to fully evaluate the use of guideline citations for researcher evaluation 
until more countries systematically add references to their guidelines so this article employs 
two questions that can start to assess their value. 
• Are articles that are cited in clinical guidelines more highly cited in the academic 
literature than other similar articles? A positive answer would suggest that guideline 
citations might not be needed for evaluating researchers because the extra value of 
the articles would already be reflected to some extent by traditional academic 
citations.  
• Do articles that are cited in clinical guidelines attract (a) more Mendeley readers and 
(b) more Mendeley readers with an occupation classed as “Other Professional” in 
comparison to similar articles? A positive answer to (a) would suggest that Mendeley 
readership could at least partly reflect the impact of articles cited in clinical 
guidelines. A positive answer to (b) would suggest the same for the other 
professional readers’ category to check because it is the only non- academic reader 
category and so would presumably contain all non-academic medical practitioners 
using Mendeley. 
In the research questions academic citations are logical to check because they are widely 
used. Mendeley readers are also worth checking because they are a particularly promising 
source of altmetrics (Priem, Taraborelli, Groth, & Neylon, 2010) and the only one that 
categorises users into professional groups (Li, Thelwall, & Giustini, 2012; Mohammadi, 
Thelwall, Haustein, & Larivière, in press; Zahedi, Costas, & Wouters, 2013). 
Methods	
NICE CKSs were downloaded in July 2014 from the alphabetical clinical topic list on the 
home page of cks.nice.org.uk. To check for unlisted guidelines, Google and Bing were 
searched with the following three queries and their results checked against the existing list. 
• site:cks.nice.org.uk "free full-text" 
• site:cks.nice.org.uk "references" 
• site:cks.nice.org.uk "last revised in" 
This process resulted in a list of 327 CKSs, excluding one that was missing from the site at 
the time of downloading.  A program was written to parse the references in the guidelines 
(now added to Webometric Analyst) to extract the authors, publication year, title, journal 
name, volume and issue from each one. Only articles published in journals were considered 
because these have a natural comparison set of other articles in the same journal and year 
and possibly also in the same volume or issue. This gave 6128 references. 
To check the relative academic citation level for clinical guidelines-cited articles, each 
article was ranked in its journal issue using the formula (rank-1)/(articles-1), which is called 
here the normalised citation rank. This gives a number between 0 and 1, with 0.5 meaning 
that the article has received the issue median number of citations (but not vice versa due to 
ties). If articles cited in clinical guidelines tend to have rank scores greater than 0.5 then this 
suggests that academic citations reflect their applied values to some extent. Scopus was 
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used for the citations in preference to the Web of Science since its wider coverage could 
encompass more applied research and hence more citations to the guideline-cited articles. 
Issues were found in Scopus for 4516 of the references (66%). The missing articles seemed 
to be in journals not indexed by Scopus at the time that the article was published. 
Moreover, in some cases the names of the journals in the references did not match the 
name of the journal in Scopus due to abbreviation, miss-spelling or alternative name 
formats (e.g., The BMJ, BMJ, The British Medical Journal). 
The above was repeated using Mendeley reader counts extracted from the 
Mendeley Applications Programming Interface (API) by Webometric Analyst (Mendeley tab). 
Mendeley reports the total number of readers for an article and the percentage of readers 
in the top three occupation categories for the article. When one of these categories 
included the ‘other professional’ category its percentage was multiplied by the number of 
article readers and rounded to get the number of ‘other professional’ readers. When this 
class not was mentioned, it was assumed that there were no such readers, although there 
may have been a small number.  
Results	
The earliest cited article was from 1933 and the median age of the cited articles was 2004, 
with a clear skew towards relatively recent research, although the peak was seven years ago 
in 2007 (Figure 1). The distribution reflects the guidelines being compiled and updated at 
different times and so some are more recent than others. The median last updated date of 
the CKSs from which the references were taken was 2012, although the CKS service began in 
March-April 2007 (Smart, 2007) and replaced a previous computer-based service, PRODIGY, 
which had begun in 1998 (Wilson, Purves, & Smith, 1999). The 2007 reference peak in Figure 
1 possibly reflects a degree of conservatism in the CKS references from the foundation date, 
although summaries on new topics have been created since then. 
 
Figure 1. Journal articles extracted from NICE CKSs and journal articles analysed by year. 
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There is clear evidence that CKS references that are journal articles are much more highly 
cited than other journal articles from the same issue. For all the years combined the mean 
normalised citation rank is 0.80, with a 95% confidence interval of (0.80, 0.81). This citation 
advantage is stable over time, except for the most recent articles, which presumably will 
show the same pattern after more time has elapsed to attract citations (Figure 2).  
 
 
Figure 2. Mean normalised citation ranks for articles in NICE CKS references by year. Error 
bars indicate 95% confidence intervals for the mean. 
 
Mendeley reader counts and Mendeley Other Professional reader counts also point to NICE 
CKS references being more cited than comparable articles, but their rank advantage is less 
pronounced (figures 3 and 4). The reason for the lower rank advantage is that there are 
many fewer Mendeley readers than there are citers (the overall means were 142.5 for 
citations, 17.1 for readers and 1.74 for Other Professionals). Mendeley readers were more 
numerous than citers for the most recent full year, however (in 2013 the means were 13.2 
for citations, 23.62 for readers and 1.57 for Other Professionals) so they may be useful 
impact indictors for very recent articles (much longer time periods have been suggested for 
another discipline: Maflahi & Thelwall, in press). 
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Figure 3. Mean normalised Mendeley reader ranks for articles in NICE CKS references by 
year. Error bars indicate 95% confidence intervals for the mean. 
 
 
Figure 4. Mean normalised Mendeley Other Professional reader ranks for articles in NICE 
CKS references by year. Error bars indicate 95% confidence intervals for the mean. 
Discussion	
The results show that CKS references tend to be much more highly cited than comparable 
articles in the sense that they tend to fall within the top 20% most cited articles in their 
journal issue. This suggests that their applied value is reflected through increased citations 
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but other explanations are also possible. In particular, CKS references could tend to be 
published in low impact journals for their specialism, and hence are highly ranked in their 
issue, although this seems to be unlikely. This is hard to check directly in a fair way because 
there are many very low-ranked journals, including those outside of Scopus and WoS. As an 
indirect and partial check, Spearman correlations were calculated between the normalised 
citation rank of journals and the mean number of citations per article in the journal issue. 
This correlation was calculated separately for articles published in the peak year, 2007, and 
the two previous years. If a moderate proportion of CKS references were published in low 
impact journals then, other factors being equal, a negative correlation could be expected 
because articles in lower impact issues would tend to attract more citations than articles in 
higher impact issues. All three correlations were small and insignificant, however (2007: 
rho=-0.014, p=0.773, n=450; 2006: rho=0.023, p=0.639, n=424; 2005: rho=-0.029, p=0.590, 
n=351), suggesting that this is not a factor and so CKS references probably do not tend to be 
published in low impact journals for their specialism. 
The results are limited to the UK NICE CKS references but it seems likely that a 
similar pattern would be evident for any carefully compiled set of references from clinical 
guidelines. 
 It is not clear whether the CKS references tend to be more highly cited because they 
are more valuable or because they have the extra publicity of being in CKS guidelines. Both 
may be true but, from the perspective of research evaluation, this probably does not 
matter. It is also possible that more highly cited articles are more likely to be added to 
clinical guidelines because their citations make them easier to find (e.g., more highly ranked 
in systems that use citations for ranking, and easier to find through the citations in other 
documents). 
To give additional context to Figure 2, only nine articles were the single least cited in 
the issue in which they were published (see Table 1), but 1097 were the single most cited. 
Four of the nine lowest-ranked articles had attracted no Scopus citations, although all 
except one of these had attracted a few Google Scholar citations (13 for The management of 
acute bronchitis in children, 3 for Accuracy of cardiovascular risk estimation and 1 for 
Hormonal breast cancer agents: implications for the primary care provider). The articles all 
seem to be valuable and hence it is plausible that they would be undervalued by citation 
counts. Thus it is possible that some articles cited in clinical guidelines are undervalued by 
citation counts, even though it may not be common. Nevertheless, only one of the articles is 
a traditional primary research report and some are clearly practitioner-oriented, suggesting 
that such literature may be particularly undervalued by citations. 
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Table 1. The 9 articles with the fewest articles in their issue out of the 4993 articles for 
which issues were found. 
Guideline 
Last 
revised 
Referenced article title 
[comment] Journal Year 
Issue 
cit. 
Issue 
size 
Article 
cit. 
Herpes simplex 
- oral 
 Sept. 
2012 
A risk-benefit evaluation of 
aciclovir for the treatment 
and prophylaxis of herpes 
simplex virus infections 
[review article] Drug Safety 23(2) 2000 446 6 15 
CVD risk 
assessment and 
management 
 Dec. 
2008 
Accuracy of cardiovascular 
risk estimation [letter] Clinical Chemistry 49(4) 2003 1584 42 0 
Achilles 
tendinopathy 
 April 
2010 
Achilles tendinopathy 
[practitioner-oriented review] 
Critical Reviews in 
Physical and 
Rehabilitation Medicine 
16(2) 2004 26 4 3 
Tamoxifen - 
managing 
adverse effects 
 Feb. 
2009 
Hormonal breast cancer 
agents: implications for the 
primary care provider [review 
article] 
Journal of the American 
Academy of Nurse 
Practitioners 18(11) 2006 26 7 0 
Cough - acute 
with chest signs 
in children 
 Oct. 
2012 
The management of acute 
bronchitis in children [expert 
review article] 
Expert Opinion on 
Pharmacotherapy 8(4) 2007 161 12 0 
Halitosis 
 Jan. 
2010 
Effects of sodium lauryl 
sulphate (SLS), present in 
dentifrice, on volatile sulphur 
compound (VSC) formation in 
morning bad breath [article - 
randomized controlled trial] 
Journal of the 
International Academy of 
Periodontology 10(4) 2008 11 3 2 
Itch - 
widespread 
 Feb. 
2010 
Novel agents for intractable 
itch [informal practitioner 
review article] Skin Therapy Letter 13(1) 2008 20 2 5 
Meibomian 
cyst 
 May 
2010 
The eyelids: some common 
disorders seen in everyday 
practice [review article] Geriatrics 64(4) 2009 20 4 1 
Hypothyroidism 
 
February 
2011 
Hypothyroidism in pregnancy: 
do guidelines alter practice? 
[editorial] Thyroid 20(3) 2010 228 20 0 
 
 
Conclusions	
The positive results undermine the need for specific guideline metrics because, if articles are 
evaluated through their citations then articles in CKS references will tend to be more highly 
cited and hence will tend to be rewarded even without singling out their applied value. 
Nevertheless, it is not clear whether the reward from enhanced citations would be enough 
or whether an additional guideline-specific metric would also be needed. Perhaps more 
importantly, although the citation rank advantage of these articles is lower for articles from 
the previous three years (after 2011 in Figure 2 the articles have lower citation rank 
advantages), this may well be due to the smaller number of citations available for more 
recent articles, which reduces the discriminatory power of the citation rank advantage 
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statistic. Explicit guideline metrics may therefore be needed if recent articles are to be 
assessed, as is often the case.  
The data from Mendeley gave a less clear indication of the value of CKS references 
than did the citation data. This is probably because there were many fewer readers than 
citers for most years, making the rank-based statistics less powerful. Although the Other 
Professional category in Mendeley could include medical professionals that use clinical 
guidelines but that do not publish research, few of these were found for the CKS references. 
Mendeley statistics are therefore not currently useful for assessing the professional impact 
or academic impact of medical guideline references, except perhaps for very recent articles. 
In terms of future work, it would be useful to assess other guidelines to confirm that 
the pattern found is not unique to NICE and also to compare the references between 
guidelines to assess the extent to which the same references are used. For example, it may 
be that some references are unique and irreplaceable but others are more a matter of 
choice. Presumably the unique references would be the most highly cited. It would also be 
useful to attempt a finer-grained assessment of references in guidelines that give quality 
indicators to their references (Restrepo, 2010) to see if these can help to identify 
particularly important citations. 
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